ZBeats Receives FDA Clearance for 14 Day ECG Analysis
ZBeats received U.S. Food and Drug Administration 510(k) clearance for ZBPro Diagnostic v2.0, the company announced in a press release. The clearance expands the ECG analysis platform to support recordings lasting from one minute to 14 days, including Holter configurations and wearable patches.
ZBPro v2.0 provides automated retrospective analysis of beats and rhythms, including atrial fibrillation detection. It combines NoiseGuard with a common intelligence layer that converts data from supported recording technologies into a consistent format for ECG analysis.
The platform also includes tools for review, editing, reporting, configurable permissions, and clinical workflows. ZBeats, which describes ZBPro as combining AI driven analysis with review and reporting tools, plans to present the cleared version at HRX Live 2026 in Atlanta from 18 to 20 September.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 16 Linearis Joins Two Canadian AI Health Data Projects Sep 16 Astrin Names Medical Director as Certitude Breast Expands Nationwide Sep 16 Amgen Selects Veeva Vault CRM for Global Deployment Sep 16 Medallion Acquires Andros for Healthcare Credentialing Sep 16 SENA Health Raises Series A for AI Care CoordinationLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Empatica Gets FDA Clearance for Parkinson's Monitoring Platform
Sky Labs Presents CART Blood Pressure Studies at ESC 2026
Cortechs.ai Gets FDA Clearance for NeuroQuant PET
Apple Health Adds Health Age and Readiness Scores
Bioness Adds OneStep Smartphone Gait Analysis to Rehabilitation Devices
Daily AI Brief: the AI news that matters, in your inbox.